Ali Pashazadeh, Treehill Partners CEO, adds to a discussion on Clinical Trials Arena about how the correct interpretation and use of data is key to pharmaceutical asset development success.
Read the full article:
https://www.clinicaltrialsarena.com/features/data-management-too-much-blessing-burden